Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Apricus Biosciences: A Victim of Market Hysteria
Seeking Alpha
Wednesday, August 10, 2011 - 7:35pm
tags:
Apricus Biosciences, NexACT
Orexigen Revisited: Chances for Contrave Approval Seem Slim
Seeking Alpha
Wednesday, August 10, 2011 - 5:29pm
tags:
Contrave, Orexigen, obesity
J&J, Gilead HIV Drug Wins FDA Approval
Bloomberg
Wednesday, August 10, 2011 - 5:28pm
tags:
Gilead, JNJ, Complera, HIV, FDA, Edurant, Truvada
Merck Vioxx Lawyers Get More Fees After Filing Objections
Bloomberg
Wednesday, August 10, 2011 - 5:25pm
tags:
Merck, Vioxx
Icagen 2Q net loss increases
Bizjournals.com
Wednesday, August 10, 2011 - 5:24pm
tags:
earnings, Icagen
Amarin Reports Second Quarter 2011 Results
Yahoo
Wednesday, August 10, 2011 - 10:51am
tags:
Amarin, earnings
DOJ Subpoena May Rattle Old Skeletons in Merck’s Closet
BNET Pharma
Wednesday, August 10, 2011 - 10:50am
tags:
hepatitis C, melanoma, cancer, Intron A, Temodar, DOJ, PegIntron, Merck
A Former Pharma Ghostwriter Speaks Out
Forbes
Wednesday, August 10, 2011 - 10:48am
tags:
Ghostwriting
Drug Maker Dividend Stocks With Strong Growth Prospects
Seeking Alpha
Wednesday, August 10, 2011 - 10:47am
tags:
Pfizer, Merck, Bristol-Myers Squibb, Novartis, Takeda, Sanofi, Eli Lilly, GSK, Roche, AstraZeneca, dividends
Johnson & Johnson Reaches Agreement With U.S. on Risperdal Criminal Charge
Bloomberg
Wednesday, August 10, 2011 - 10:44am
tags:
off-label, antipsychotics, Risperdal, JNJ
Yervoy may face Roche rival sooner than expected
Fierce Pharma
Tuesday, August 9, 2011 - 6:29pm
tags:
Bristol-Myers Squibb, Zelboraf, melanoma, Yervoy, Roche
Merck, Pfizer Among Cash Stashers as Markets Gyrate
Motley Fool
Tuesday, August 9, 2011 - 6:28pm
tags:
Pfizer, Merck, stocks
Are Eli Lilly's Earnings Better Than They Look?
Motley Fool
Tuesday, August 9, 2011 - 6:27pm
tags:
Eli Lilly, earnings
Reps Wield iPADs, But Most Docs Not Impressed
Pharmalot
Tuesday, August 9, 2011 - 1:52pm
tags:
physicians, iPad, drug reps
Do Prescription Drugs Add to, Shift, or Reduce Healthcare Costs?
Pharmareform
Tuesday, August 9, 2011 - 1:51pm
tags:
drug marketing, healthcare reform, PBMs
Zeltia Says Yondelis-Related Drug May Suffer Supply Constraints
Bloomberg
Tuesday, August 9, 2011 - 1:48pm
tags:
Europe, Caelyx, JNJ, Yondelis, Zeltia
Good Biotech Stocks for a Bear Market
TheStreet.com
Tuesday, August 9, 2011 - 1:27pm
tags:
Elan, Targacept, Dendreon, Gilead Sciences, Sequenom, Vertex Pharmaceuticals, Amgen, Alexion, Biogen Idec, Celgene
GenVec narrows loss on higher revenue
Bizjournals.com
Tuesday, August 9, 2011 - 1:14pm
tags:
GenVec, earnings
Biogen and Abbott advance MS drug candidate
Bizjournals.com
Tuesday, August 9, 2011 - 1:13pm
tags:
DAC HYP, multiple sclerosis, MS, Abbott Laboratories, Biogen Idec, dalcizumab HYP
Lower Spend Narrows Loss at Vivus
Yahoo/Zacks.com
Tuesday, August 9, 2011 - 10:11am
tags:
Vivus, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.